Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Can Ozempic and Wegovy cause 'stomach paralysis' and 'cyclic vomiting'?

"Stomach paralysis" linked to drugs like Ozempic has raised alarm. What do doctors make of the reports?

LiveScience

Elon Musk-Backed Brain Chip Company Neuralink Gets $280 Million In Funding

Neuralink receives approval from the FDA for human experiment trials as experimentation looms.

Zenger

Is Eli Lilly Stock A Sell After Kennedy-Tied Woes Rankled Shares?

Eli Lilly stock has dropped since Trump announced his plan to appoint Kennedy to the HHS lead role. Is LLY stock a sell?

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

What we know — and don't know — about the FDA-approved postpartum depression pill

Postpartum depression affects as many as 1 in 7 women in the U.S., though there are just two treatments approved for it. Experts say the newest could be a game-changer — depending on its price tag.

WEKU

3 Pharma Stocks Investors Are Chasing for Value

With the advent of advanced medications and the increasing need for personalized treatments, the pharmaceutical industry looks well-poised for long-term growth. Therefore, it could be worth looking into three fundamentally sound pharma stocks, Pfizer (PFE), Sanofi (SNY), and GSK plc (GSK), that are offering significant value. Read more….

StockNews.com

More gay men can donate blood—here's why

A policy that wasn't rooted solely in science is diminished, but certain barriers to blood donation still remain

Salon

Here's Why Embattled Apellis Stock, A Former Highflier, Just Took Another Hit To The Chin

Astellas Pharma won FDA approval for a rival to Apellis Pharmaceuticals' eye-disease treatment and APLS stock plunged Monday.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Why Sage Lost Half Its Value After The FDA Approved Its Depression Drug

Sage stock plummeted Monday after the FDA approved its drug, Zurzuvae, in postpartum depression, but not major depressive disorder.

Investors Business Daily

Up First briefing: Trump fights protective order; FDA approves postpartum pill

Donald Trump's legal team has until 5:00 p.m. to respond to prosecutors' request for a protective order. The FDA has approved the first pill to treat postpartum depression.

WEKU

Ozempic and Wegovy maker courts prominent Black leaders to get Medicare's favor

Drugmaker Novo Nordisk focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease — worth treating at a cost of $1,000 or more a month.

WEKU

Frito-Lay's Doritos Added to Recall List

A new Food and Drug Administration (FDA) recall was just announced for Doritos.

The Street

FDA approves postpartum depression pill

Here’s what we know about the second drug to ever be approved for the post-pregnancy condition

Salon

RSV prevention shot for babies gets OK from CDC

The monoclonal antibody drug prevents the lung infection that puts 58,000 to 80,000 young children in the hospital each year.

WEKU

The FDA approves the first pill specifically intended to treat postpartum depression

The Food and Drug Administration granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 days.

WEKU

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

FDA approves first postpartum depression pill

Federal health officials have approved the first pill to specifically treat depression after childbirth

Zenger

Nikola’s Abrupt CEO Transition, Carl Icahn Led Icahn Enterprises Cuts Dividend Payout, FDA Rejects Mesoblast’s Cell Therapy For Kids: Today’s Top Stories

Wall Street Journal UAW Demands Significant Wage Increases For Factory Workers At GM, Ford, And Stellantis

LiveScience

'Powerful' new RSV prevention drug should be available to all infants this fall, CDC says

Come fall, a new antibody drug should be available to protect U.S. newborns and infants younger than 8 months from severe RSV infections.

StockNews.com

3 Biotech Stocks Smart Money Is After

Biotech companies such as Biogen (BIIB), Cidara Therapeutics (CDTX), and Theratechnologies (THTX) with the interest of institutional investors could be worth investing in now. Continue reading….

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Nearly half of US adults are interested in taking weight loss prescription drugs, survey finds

Ozempic, a once-weekly semaglutide injection, has grown in popularity for its weight loss side effects

Fortune

Zuranolone: What to know about the breakthrough postpartum depression treatment just approved by the FDA

“It’s like Z-Pak for depression,” one expert told Fortune.

LiveScience

Could an antibiotic taken after unprotected sex prevent STIs? What to know about doxy-PEP.

This summer, the CDC is expected to release guidelines for the use of doxy-PEP to prevent STIs. But what is it, and why is everyone talking about it now?

The Independent UK

Two lots of Tydemy birth control pills are under recall. The FDA warns of 'reduced effectiveness'

Federal regulators are warning consumers that now-recalled lots of the Tydemy birth control pill “may have reduced effectiveness” due to decreased levels of a key ingredient of the product

Zenger

Mixed Jobs Report Signals Uncertainty In US Economy

Unemployment rate drops, but job additions fall short of expectations, impacting Fed's interest rate decisions.

StockNews.com

Are These Biotech Stocks a Buy or Sell for August: Bionano Genomics (BNGO) vs. Cidara Therapeutics (CDTX)?

Underpinned by undeniable growth trends of an aging population, breakthrough therapies, and the inelastic demand for healthcare products and medicines, the biotech industry is expected to perform well in the near term. Given this backdrop, let’s compare two biotech stocks, Bionano Genomics (BNGO) and Cidara Therapeutics (CDTX), to determine if…

Salon

The battle against lead in turmeric

"This [FDA] guideline did not discuss spices and no maximum limits for lead are noted for adults"

1 … 52 53 54 55

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.